PORCN and neoplasm: Finally, PORCN inhibition significantly suppressed PDX tumor development of RNF43‐mutant CRC cells, suggesting that PORCN inhibitors are an effective therapeutic strategy against RNF43‐mutant CRC development and metastasis.